well so far all the court cases seem to last years for resolution. Take our Jublia Generic for example.......... ANDA filed 2017(?) orange book...... court case 2018ish, where we in 2022 still don't know the outcome....... even though the US FDA has given us approval for our Jublia Generic ( as well as some 10 others) but ACR cannot launch the product. So if Dapsone follows the same path it'll be 2030 before we are even told how it went.
- Forums
- ASX - By Stock
- ACR
- Ann: Acrux confirms patent challenge
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.9¢

Ann: Acrux confirms patent challenge, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.747M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $5.562K | 292.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 381825 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 60000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 331825 | 0.019 |
3 | 381800 | 0.018 |
1 | 175000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 60000 | 2 |
0.021 | 177000 | 1 |
0.022 | 18000 | 1 |
0.023 | 73278 | 3 |
0.024 | 254102 | 7 |
Last trade - 15.04pm 20/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |